Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt-Ingram Cancer Center
Study ID
NCT01205815
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tissue and blood collection — OTHER
    Tissue will be obtained from a previous biopsy if available, or if unavailable, tissue will be collected from a scheduled biopsy. About3-4 teaspoons of blood will be collected.

Study Details

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Key Dates

Start date
Jun 3, 2010
Status verified
Mar 2025
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

Molecular changes in patients' melanoma tissue [ Time Frame: at 120 months ]

Central Contacts

  • Vanderbilt-Ingram Service for Timely Access
    800-811-8480

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbitl-Ingram Cancer CenterNashvilleTennessee-
Vanderbilt-Ingram Service for Timely Access
800-811-8480
Douglas Johnson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Nashville, TN

By condition
Melanoma
By specialty
OncologySkin cancerDermatology
By research site
Vanderbitl-Ingram Cancer Center· Nashville, TN

Related Studies